Bibliography
- SMYTHE JA, SUN D, THOMSON M et al.: A rev-induciblemutant gag gene stably transferred into T lymphocytes: an approach to gene therapy against human immuno-deficiency virus type 1 infection. Proc. NatL Acad. Sci, USA (1994) 91:3657–3661.
- HOPE TJ, KEIN NP, ELDER ME et al.: Transdominant inhi-bition of human immunodeficiency virus type 1 Rev oc-curs through formation of inactive protein complexes. J. ViroL (1992) 66:1849–1855.
- MARASCO WA, HASELTINE WA, CHEN S-Y: Design, intra-cellular expression and activity of a human anti-human immunodeficiency virus type 1 gp120 single chain anti-body. Proc. Natl. Acad. Sci, USA (1993) 90:7889–7893.
- SARVER N, CANTIN E, CHANG P et al.: Ribozymes as po-tential anti-HIV therapeutic agents. Science (1990) 247:1222–1225.
- LISZIEWICZ J, SUN D, SMYTHE J et al.: Inhibition of hu-man immunodeficiency virus type 1 replication by regulated expression of a polymeric Tat activation re-sponse RNA decoy as a strategy for gene therapy in AIDS. Proc. Natl. Acad. Sci, USA (1993) 90:8000–8004.
- BAIER M, WERNER A, BANNERT N, METZNER K, KURTH R: HIV suppression by IL-16. Nature (1995) 378:563.
- CENTER DM, KORNFELD H, CRUIKSHANK WW: Interleukin-16 and its function as a CD4 ligand. Immu-noL Today (1996) 17:476–481.
- CRUIKSHANK WW, CENTER DM, NISAR et al.: Molecular and functional analysis of a lymphocyte chemoattrac-tant factor: association of biological function with CD4 expression. Proc. Natl. Acad. Sci, USA (1994) 91:5109–5119.
- BANNERT N, BAIER M, WERNER A, KURTH R: Interleukin-16 or not? Nature (1996) 381:30.
- BAZAN JF, SCHALL TJ: Interleukin-16 or not? Nature (1996) 381:29–30.
- BAIER M, BANNERT N, WERNER A, LANG K, KURTH R: Mo-lecular cloning, sequence, expression and processing of the interleukin-16 precursor. Proc. Natl. Acad. Sci, USA (1997) 94:5273.
- MACIASZEK JW, PARADA NA, CRUIKSHANK WW et al.: IL-16 represses 11IV-1 promoter activity. J. ImmunoL (1997) 158:5–8.
- ZHOU P, GOLDSTEIN S, DEVADAS K, TEWARI D, NOTKINS AL: Human CD4 + cells transfected with IL-16 cDNA are resistant to 11IV-1 infection: inhibition of mRNA ex-pression. Nature Medicine (1997) 3:659–664.
- LEVY AJ, MACKEWICZ CE, BARKER E: Controlling HIV pathogenesis: the role of the noncytotoxic anti-HIV re-sponse of CD8+ T cells. ImmunoL Today (1996) 17:218–224.
- COCCHI F, DEVICO AL, GARZINO-DEMO A et al.: Identifi-cation of RANTES, MIP-lalpha and MIP-lbeta as the ma-jor HIV-suppressive factors produced by CD8+ T cells. Science (1995) 270: 1811-1815.
- BLEUL CC, FARZAN M, CHLOE H et al.: The lymphocyte chemoattractant SDF-1 is the ligand for LESTR/fusin and blocks HIV entry. Nature (1996) 382:829–833.